The National Cancer Institute has awarded Ben Major, PhD, assistant professor of Cell Biology and Physiology, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with an R21 award of $275,000 to support his project “Mass spectrometry-coupled hypermorphic functional genomics”. The goal of the research is to develop gain-of-function screening technology to connect gene overexpression with signal transduction in cancer.
Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.
UNC Health Care and Rex Healthcare co-sponsored “Field of Hope” at the Durham Bulls game on Saturday, August 23 with a portion of special ticket sales going to the Kay Yow Cancer Fund.
The Lung Cancer Initiative of NC hosted a statewide Lung Cancer Summit on August 23 at the N.C. Cancer Hospital. Lung cancer advocates were bolstered with training, resources, knowledge and the courage to take action. UNC Lineberger Comprehensive Cancer Center was the Host Sponsor of the event.
For more than 20 years, Sharon Campbell, PhD, has been studying Ras, a protein implicated in 30 percent of all cancers. Now she’s on the hunt for alternative ways to shut the protein down.
Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.
UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic “drivers” of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy. The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.
Part of More Than $24.7 Million Awarded in New Grants by the St. Baldrick’s Foundation
An international scientific collaboration led by researchers at UNC has revealed new insights into the unique genetic alterations that contribute to a rare form of kidney cancer.
Angiogenesis inhibitors are a class of drugs commonly used in cancer therapy. However, there isn’t a way to identify patients who will benefit the most from treatment with these drugs. A new $275,000 grant could help Federico Innocenti, MD, PhD, and his team identify such patients based on their genetic profile.
Margaret L. Gulley, MD, served as a coauthor on The Cancer Genome Atlas publication of “The Comprehensive Molecular Characterization of Gastric Adenocarcinoma” in the journal Nature. The paper identifies four subtypes of the cancer, which could provides information to allow for better patient tumor type identification and the development of targeted therapies for the cancer.
Stephanie Wheeler, PhD, and Michael Pignone, MD, MPH, published “Regional variation in colorectal cancer testing and geographic availability of care in a publicly insured population” in the journal Health and Place. The paper found that less than 50 percent of eligible individuals had evidence of colorectal (CRC) testing.
Hyman Muss, MD, and Grant Williams, MD, published “Feasibility of geriatric assessment in community oncology clinics” in the Journal of Geriatric Oncology. The paper showed that performing a geriatric assessment in a community oncology clinic can be done in a similar timeframe as in an academic setting.
UNC Lineberger members David Margolis, MD, and Ronald Swanstrom, PhDm were both recently published in the journal Science.
A substantial number of older patients with limited life expectancy receive routine screenings for prostate, breast, cervical and colorectal cancer even though the procedures are unlikely to benefit them, according to research conducted at the University of North Carolina at Chapel Hill.
UNC Lineberger Comprehensive Cancer Center has awarded nine researchers with Developmental Research Awards to support their work in advancing the fields of clinical/translational and population science cancer research.
A recent article published in the July/August 2014 issue of Health Leaders magazine focuses on some of UNC Lineberger’s strengths that rank it among the nation’s leading cancer centers.
A recent U.S. News & World Report article highlights the nation’s cancer centers, focusing especially on those that the National Cancer Institute has designated as comprehensive cancer centers, citing advantages of patients being seen at or referred to these sites, including advances in technology and collaboration.
Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill and other TCGA sites, not only revamps traditional ideas of how cancers are diagnosed and treated, but could also have a profound impact on the future landscape of drug development.
Jean B. Sellers, RN, MSN has co-authored a chapter in the newly published book, Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum.